Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers
Is a
Allocation Type
Randomized
0
Intervention Model
Parallel Assignment
0
Intervention Name
VXA-G1.1-NN Oral Vaccine
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Prevention
0
Intervention Type
Biological
0
Last Updated
May 30, 2018
0
Masking Type
None (Open Label)
0
Primary Completion Date
July 1, 2017
0
Trial Recruitment Size
66
0
Trial Sponsor
Clinical Trial Start Date
April 7, 2017
0
Study Completion Date
May 6, 2018
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 1b, Open-Label, Dose-Optimization Trial of an Adenoviral-vector Based Norovirus Vaccine (VXA-G1.1-NN) Expressing GI.1 VP1 and dsRNA Adjuvant Administered Orally to Healthy Volunteers
0
Official Website
Find more entities like Dose-Optimization Trial of VXA-G1.1-NN in Healthy Volunteers
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.